Thrivent Financial for Lutherans
LEGN icon

Thrivent Financial for Lutherans’s Legend Biotech LEGN Stock Holding History

Thrivent Financial for Lutherans’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-121,377
Closed -$5.92M – 2580
2024
Q3 		$5.92M Buy
121,377
+33,585
+38% +$1.79M 0.01% 861
2024
Q2 		$3.89M Sell
87,792
-31,053
-26% -$1.43M 0.01% 998
2024
Q1 		$6.67M Buy
+118,845
New +$7.17M 0.01% 779

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Thrivent Financial for Lutherans's LEGN Position: Q4 2024 in Review

Thrivent Financial for Lutherans sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 121,377 shares — an estimated $5.92M sold.

Thrivent Financial for Lutherans first reported a position in LEGN in Q1 2024 and held it in 3 quarters. The position peaked at $6.67M in Q1 2024. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

  • Thrivent Financial for Lutherans reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 121,377 Legend Biotech shares in Q4 2024, an estimated $5.92M.
  • Thrivent Financial for Lutherans first reported a position in Legend Biotech in Q1 2024 and held it in 3 quarters.
  • Thrivent Financial for Lutherans's Legend Biotech position peaked at $6.67M in Q1 2024.
  • 211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2024, filed 10 Feb 2025.